Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptima Health Regulatory News (OPT)

Share Price Information for Optima Health (OPT)

Share Price is delayed by 15 minutes
Get Live Data
187.00    0.00 (0.00%)
Bid:
185.00
Ask:
189.00
Spread: 4.00 (2.162%)
Market Cap: £203.41m
OPT Live PriceLast checked at - London Stock Exchange

Intraday Optima Health Share Chart

Directors' Dealings

20 Jul 2009 07:00

RNS Number : 9177V
Ocean Power Technologies Inc
20 July 2009
 



GRANT OF STOCK OPTIONS AND RESTRICTED SHARES TO DIRECTORS

AND DIRECTOR'S DEALING

Pennington, NJ - July 20, 2009 -- Ocean Power Technologies, Inc. (Nasdaq: OPTT and London Stock Exchange AIM: OPT) ("OPT" or the "Company"announces in compliance with the AIM Rules that on July 17, 2009, options to purchase shares of common stock, and restricted shares, under the Company's 2006 Stock Incentive Plan were granted to certain Directors of the Company. The option grants and awards of restricted shares to the following executive Directors are in connection with their annual performance reviews, as recommended by the Compensation Committee of the Board of Directors, and approved by the Board of Directors. 

In addition, on July 17, 2009, the Company received notification that Dr. George W. Taylor, Executive Chairman of OPT, sold on July 17, 2009 a total of 15,000 shares of common stock at prices ranging from US $5.20 to US $5.31 per share.

The options and restricted shares were granted to the Directors as follows:

Dr. George W. Taylor (Executive Chairman): options to purchase 30,000 shares exercisable until July 16, 2019 at US $5.30 per share and 3,000 restricted shares of common stock. Following this award and his sale of shares, Dr. Taylor holds options for 436,000 shares and 752,801 shares of common stock, including 3,000 restricted shares.

Mark R. Draper (Chief Executive Officer): options to purchase 35,000 shares exercisable until July 16, 2019 at US $5.30 per share and 4,000 restricted shares of common stock. Following this award, Mr. Draper holds options for 238,499 shares and 34,000 shares of common stock, including 34,000 restricted shares.

Charles F. Dunleavy (Chief Financial Officer): options to purchase 30,000 shares exercisable until July 16, 2019 at US $ 5.30 per share and 3,000 restricted shares of common stock. Following this award, Mr. Dunleavy holds options for 347,500 shares and 78,976 shares of common stock, including 3,000 restricted shares.

The exercise price of US $5.30 per share is equivalent to the closing market price of the Company's Common stock on the Nasdaq market on July 17, 2009. The stock options issued to Dr. Taylor, Mr. Draper and Mr. Dunleavy are contingent on the approval by the Company's shareholders at their next annual meeting later this year for an increase in stock-based compensation authorized for issuance under the Company's 2006 Stock Incentive Plan.

  About Ocean Power Technologies

Ocean Power Technologies, Inc. (Nasdaq: OPTT and London Stock Exchange AIM: OPT) is a pioneer in wave-energy technology that harnesses ocean wave resources to generate reliable, clean and environmentally-beneficial electricity. OPT has a strong track record in harnessing wave energy and participates in a $150 billion annual power generation equipment market. The Company's proprietary PowerBuoy® system is based on modular, ocean-going buoys that capture and convert predictable wave energy into low-cost, clean electricity. The Company is widely recognized as a leading developer of on-grid and autonomous wave-energy generation systems, benefiting from over a decade of in-ocean experience. OPT's technology and systems are insured by Lloyds Underwriters of London. OPT is headquartered in PenningtonNew Jersey with offices in WarwickUK. More information can be found at www.oceanpowertechnologies.com.

Contact information:

Ocean Power Technologies, Inc.

Mark R. Draper, Chief Executive Officer

Charles F. Dunleavy, Chief Financial Officer 

Telephone: +1 609 730 0400

Telephone: +1 609 730 0400

Nomura Code Securities Limited

Juliet Thompson, Richard Potts

Telephone: +44 20 7776 1200

Media Contact: 

Corfin Communications 

Neil Thapar, Martin Sutton, Claire Norbury

Telephone: +44 20 7977 0020

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLKLLFKDBFBBV
Date   Source Headline
29th May 20268:34 amRNSHolding(s) in Company
27th May 202612:40 pmRNSHolding(s) in Company
18th May 202610:51 amRNSHolding(s) in Company
13th May 202612:12 pmRNSHolding(s) in Company
12th May 20265:32 pmRNSHolding(s) in Company
12th May 20261:00 pmRNSHolding(s) in Company
5th May 202610:22 amRNSHolding(s) in Company
5th May 20268:58 amRNSHolding(s) in Company
30th Apr 20263:36 pmRNSHolding(s) in Company
29th Apr 20266:02 pmRNSHolding(s) in Company
28th Apr 202610:39 amRNSHolding(s) in Company
28th Apr 20267:00 amRNSDirector/PDMR Shareholding
27th Apr 20264:27 pmRNSHolding(s) in Company
27th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 20263:57 pmRNSResult of GM and Underwritten Open Offer
17th Apr 20267:00 amRNSFull Year Trading Update
31st Mar 20267:00 amRNSLaunch of Underwritten Open Offer
30th Mar 20263:20 pmRNSHolding(s) in Company
24th Mar 20264:37 pmRNSIrish FDI Clearance & Expected Acquisition of PAM
23rd Mar 20267:00 amRNSDirectorate Change
12th Mar 20264:04 pmRNSHolding(s) in Company- Replacement
12th Mar 20267:00 amRNSContract Win
12th Mar 20267:00 amRNSContract Win
5th Mar 20263:50 pmRNSHolding(s) in Company
4th Mar 20263:33 pmRNSHolding(s) in Company
24th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Feb 20267:00 amRNSAppointment of Joint Broker
16th Feb 20267:00 amRNSAcquisition of PAM Healthcare Limited
9th Feb 20269:04 amRNSHolding(s) in Company
2nd Feb 20264:26 pmRNSHolding(s) in Company
10th Dec 20257:00 amRNSInterim Results
13th Nov 20257:00 amRNSNotice of Half Year Results
6th Nov 20252:17 pmRNSHolding(s) in Company
3rd Nov 20255:14 pmRNSHolding(s) in Company
3rd Nov 202511:15 amRNSHolding(s) in Company
3rd Nov 20257:00 amRNSHalf Year Trading Update
31st Oct 20252:00 pmRNSHolding(s) in Company
31st Oct 202511:06 amRNSHolding(s) in Company
20th Oct 20254:35 pmRNSHolding(s) in Company
29th Sep 20252:06 pmRNSHolding(s) in Company
23rd Sep 20257:00 amRNS-ROptima Health launches Optima Health Ireland
1st Sep 20254:06 pmRNSResult of AGM
4th Aug 202510:31 amRNSHolding(s) in Company
1st Aug 20252:55 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSNotice of AGM and posting of Annual Report
14th Jul 20253:21 pmRNSHolding(s) in Company
9th Jul 20256:02 pmRNSHolding(s) in Company
8th Jul 20257:00 amRNSFull Year Results
2nd Jul 202512:49 pmRNSHolding(s) in Company
30th Jun 20251:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.